Research progress of bariatric embolization for treatment of obesity

por Zhong, Bin-Yan, Li, Pei-Cheng, Ni, Cai-Fang
Publicado 2019

Subsequent Treatment after Transarterial Chemoembolization Failure/Refractoriness: A Review Based on Published Evidence

por Zhang, Shen, Wang, Wan-Sheng, Zhong, Bin-Yan, Ni, Cai-Fang
Publicado 2022

Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition

por Zhang, Shen, Zhong, Bin-Yan, Zhang, Lei, Wang, Wan-Sheng, Ni, Cai-Fang
Publicado 2022

Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma

por Zhong, Bin-Yan, Jin, Zhi-Cheng, Chen, Jian-Jian, Zhu, Hai-Dong, Zhu, Xiao-Li
Publicado 2023

Large Paraumbilical Vein Shunts Increase the Risk of Overt Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Placement

por Tang, Hao-Huan, Zhang, Zi-Chen, Zhao, Zi-Le, Zhong, Bin-Yan, Fan, Chen, Zhu, Xiao-Li, Wang, Wei-Dong
Publicado 2022

Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib

por Zhong, Bin-Yan, Yan, Zhi-Ping, Sun, Jun-Hui, Zhang, Lei, Hou, Zhong-Heng, Zhu, Xiao-Li, Wen, Ling, Ni, Cai-Fang
Publicado 2021

Stratification of portal vein-invaded hepatocellular carcinoma treated with transarterial chemoembolization monotherapy

por Zhang, Lei, Zhong, BinYan, Hu, Bo, Li, Wei, Huang, Peng, Zhang, Shen, Song, JinJin, Ji, JianSong, Ni, CaiFang
Publicado 2020

Prognosis Prediction of CRAFITY Score in HCC Undergoing TACE Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapy

por Hu, Ze-Xin, Xu, Xiao-Yang, Wang, Ze, Huang, Jin-Tao, Li, Wan-Ci, Zhang, Shuai, Shen, Jian, Zhong, Bin-Yan, Zhu, Xiao-Li
Publicado 2023

Re-evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventionalists

por Zhong, Bin-Yan, Wang, Wan-Sheng, Zhang, Shen, Zhu, Hai-Dong, Zhang, Lei, Shen, Jian, Zhu, Xiao-Li, Teng, Gao-Jun, Ni, Cai-Fang
Publicado 2021

Recent Update on Immunotherapy and Its Combination With Interventional Therapies for Hepatocellular Carcinoma

por Huang, Jin-Tao, Zhang, Shuai, Yang, Yi-Han, Zhang, Zi-Chen, Jiang, Nan, Li, Wan-Ci, Shen, Jian, Zhong, Bin-Yan, Zhu, Xiao-Li
Publicado 2022

Development of TACE Refractoriness Scores in Hepatocellular Carcinoma

por Chen, Li, Yu, Chen-Xi, Zhong, Bin-Yan, Zhu, Hai-Dong, Jin, Zhi-Cheng, Zhu, Guang-Yu, Zhang, Qi, Ni, Cai-Fang, Teng, Gao-Jun
Publicado 2021

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for A...

por Huang, Jin-Tao, Zhong, Bin-Yan, Jiang, Nan, Li, Wan-Ci, Zhang, Shuai, Yin, Yu, Yang, Jun, Shen, Jian, Wang, Wan-Sheng, Zhu, Xiao-Li
Publicado 2022

Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization

por Zhong, Bin-Yan, Jiang, Jian-Qiang, Sun, Jun-Hui, Huang, Jin-Tao, Wang, Wei-Dong, Wang, Qi, Ding, Wen-Bin, Zhu, Xiao-Li, Ni, Cai-Fang
Publicado 2023

Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7

por Jiang, Jian-Qiang, Huang, Jin-Tao, Zhong, Bin-Yan, Wang, Wei-Dong, Sun, Jun-Hui, Wang, Qi, Ding, Wen-Bin, Ni, Cai-Fang, Zhu, Xiao-Li
Publicado 2023

Safety and Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma

por Yang, Fei, Yang, Jun, Xiang, Wei, Zhong, Bin-Yan, Li, Wan-Ci, Shen, Jian, Zhang, Shuai, Yin, Yu, Sun, Hong-Peng, Wang, Wan-Sheng, Zhu, Xiao-Li
Publicado 2022

Impact of COVID-19 Pandemic on Intervals and Outcomes of Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma

por Jin, Zhi-Cheng, Chen, Li, Zhong, Bin-Yan, Zhu, Hai-Dong, Zeng, Chu-Hui, Li, Rui, Guo, Jin-He, He, Shi-Cheng, Deng, Gang, Zhu, Xiao-Li, Ni, Cai-Fang, Teng, Gao-Jun
Publicado 2021

Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Re...

por Yang, Fei, Xu, Gui-Li, Huang, Jin-Tao, Yin, Yu, Xiang, Wei, Zhong, Bin-Yan, Li, Wan-Ci, Shen, Jian, Zhang, Shuai, Yang, Jun, Sun, Hong Peng, Wang, Wan-Sheng, Zhu, Xiao-Li
Publicado 2022

Prognostic Performance of Albumin–Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib

por Zhong, Bin-Yan, Yan, Zhi-Ping, Sun, Jun-Hui, Zhang, Lei, Hou, Zhong-Heng, Yang, Min-Jie, Zhou, Guan-Hui, Wang, Wan-Sheng, Li, Zhi, Huang, Peng, Zhang, Shen, Zhu, Xiao-Li, Ni, Cai-Fang
Publicado 2020

Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

por Meng, Xiang-Pan, Wang, Yuan-Cheng, Ju, Shenghong, Lu, Chun-Qiang, Zhong, Bin-Yan, Ni, Cai-Fang, Zhang, Qi, Yu, Qian, Xu, Jian, Ji, JianSong, Zhang, Xiu-Ming, Tang, Tian-Yu, Yang, Guanyu, Zhao, Ziteng
Publicado 2020

Prognostic nomogram on admission predicting progression for patients with nonsevere COVID-19

por Wang, Zhi, Zhong, Bin-Yan, Dai, Hui, Xu, Qiu-Zhen, Yang, Wei-Bin, Zhang, Xin, Xu, Chuan-Jun, Shu, Jin-Er, Shi, Biao, Zeng, Chu-Hui, Li, Cheng, Ji, Jian-Song, Li, Yong-Gang, Teng, Gao-Jun
Publicado 2021